Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.079 AUD | -1.25% | -3.66% | -41.48% |
Apr. 24 | Rhythm Biosciences Appoints CEO; Shares Down 3% | MT |
Mar. 21 | Rhythm Biosciences Receives AU$2.5 Million Under Rights Issue; Shares Up 3% | MT |
Sales 2022 | 2.43 3.67 | Sales 2023 | 3.1 4.68 | Capitalization | 90.11M 136M |
---|---|---|---|---|---|
Net income 2022 | -8M -12.1M | Net income 2023 | -8M -12.1M | EV / Sales 2022 | 98,363,837 x |
Net cash position 2022 | 7.43M 11.23M | Net cash position 2023 | 4.08M 6.18M | EV / Sales 2023 | 27,789,011 x |
P/E ratio 2022 |
-27.4
x | P/E ratio 2023 |
-10.8
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 59.75% |
1 day | -1.25% | ||
1 week | -3.66% | ||
Current month | -3.66% | ||
1 month | -15.05% | ||
3 months | -36.80% | ||
6 months | -57.30% | ||
Current year | -41.48% |
Managers | Title | Age | Since |
---|---|---|---|
Darren Moulton
COO | Chief Operating Officer | - | - |
Trevor Lockett
BRD | Director/Board Member | - | 17-05-31 |
Guy Carisbrooke
AUD | Comptroller/Controller/Auditor | - | 23-09-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Otto Buttula
CHM | Chairman | - | 19-10-27 |
Louis Panaccio
BRD | Director/Board Member | 67 | 17-07-31 |
Susan MacLeman
BRD | Director/Board Member | - | 23-01-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 0.079 | -1.25% | 139 500 |
24-05-09 | 0.08 | -1.23% | 27,272 |
24-05-08 | 0.081 | 0.00% | 66,289 |
24-05-07 | 0.081 | -1.22% | 147,366 |
24-05-06 | 0.082 | 0.00% | 44,199 |
Delayed Quote Australian S.E., May 09, 2024 at 08:44 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.48% | 13.1M | |
-26.80% | 10.94B | |
+65.44% | 3.75B | |
-28.13% | 2.27B | |
-10.06% | 2.25B | |
-25.01% | 1.54B | |
+50.53% | 1.18B | |
-2.84% | 754M | |
-7.83% | 529M | |
-27.35% | 469M |
- Stock Market
- Equities
- RHY Stock